U.S. flag

An official website of the United States government

NM_000038.6(APC):c.5801C>T (p.Pro1934Leu) AND Hereditary cancer-predisposing syndrome

Germline classification:
Benign/Likely benign (3 submissions)
Last evaluated:
Apr 18, 2023
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000159562.26

Allele description [Variation Report for NM_000038.6(APC):c.5801C>T (p.Pro1934Leu)]

NM_000038.6(APC):c.5801C>T (p.Pro1934Leu)

Gene:
APC:APC regulator of WNT signaling pathway [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
5q22.2
Genomic location:
Preferred name:
NM_000038.6(APC):c.5801C>T (p.Pro1934Leu)
Other names:
p.P1934L:CCC>CTC
HGVS:
  • NC_000005.10:g.112841395C>T
  • NG_008481.4:g.153875C>T
  • NM_000038.6:c.5801C>TMANE SELECT
  • NM_001127510.3:c.5801C>T
  • NM_001127511.3:c.5747C>T
  • NM_001354895.2:c.5801C>T
  • NM_001354896.2:c.5855C>T
  • NM_001354897.2:c.5831C>T
  • NM_001354898.2:c.5726C>T
  • NM_001354899.2:c.5717C>T
  • NM_001354900.2:c.5678C>T
  • NM_001354901.2:c.5624C>T
  • NM_001354902.2:c.5528C>T
  • NM_001354903.2:c.5498C>T
  • NM_001354904.2:c.5423C>T
  • NM_001354905.2:c.5321C>T
  • NM_001354906.2:c.4952C>T
  • NP_000029.2:p.Pro1934Leu
  • NP_001120982.1:p.Pro1934Leu
  • NP_001120983.2:p.Pro1916Leu
  • NP_001341824.1:p.Pro1934Leu
  • NP_001341825.1:p.Pro1952Leu
  • NP_001341826.1:p.Pro1944Leu
  • NP_001341827.1:p.Pro1909Leu
  • NP_001341828.1:p.Pro1906Leu
  • NP_001341829.1:p.Pro1893Leu
  • NP_001341830.1:p.Pro1875Leu
  • NP_001341831.1:p.Pro1843Leu
  • NP_001341832.1:p.Pro1833Leu
  • NP_001341833.1:p.Pro1808Leu
  • NP_001341834.1:p.Pro1774Leu
  • NP_001341835.1:p.Pro1651Leu
  • LRG_130t1:c.5801C>T
  • LRG_130:g.153875C>T
  • NC_000005.9:g.112177092C>T
  • NM_000038.4:c.5801C>T
  • NM_000038.5:c.5801C>T
  • p.P1934L
Protein change:
P1651L
Links:
dbSNP: rs587780600
NCBI 1000 Genomes Browser:
rs587780600
Molecular consequence:
  • NM_000038.6:c.5801C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001127510.3:c.5801C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001127511.3:c.5747C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001354895.2:c.5801C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001354896.2:c.5855C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001354897.2:c.5831C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001354898.2:c.5726C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001354899.2:c.5717C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001354900.2:c.5678C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001354901.2:c.5624C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001354902.2:c.5528C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001354903.2:c.5498C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001354904.2:c.5423C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001354905.2:c.5321C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001354906.2:c.4952C>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Hereditary cancer-predisposing syndrome
Synonyms:
Neoplastic Syndromes, Hereditary; Tumor predisposition; Cancer predisposition; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0015356; MeSH: D009386; MedGen: C0027672

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000213581Ambry Genetics
criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)
Benign
(Jun 12, 2020)
germlineclinical testing

PubMed (3)
[See all records that cite these PMIDs]

Citation Link,

SCV000681763Color Diagnostics, LLC DBA Color Health
criteria provided, single submitter

(ACMG Guidelines, 2015)
Likely benign
(Apr 18, 2023)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV002528010Sema4, Sema4
criteria provided, single submitter

(Sema4 Curation Guidelines)
Likely benign
(Dec 18, 2021)
germlinecuration

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing, curation

Citations

PubMed

Germline Mutations in Predisposition Genes in Pediatric Cancer.

Zhang J, Walsh MF, Wu G, Edmonson MN, Gruber TA, Easton J, Hedges D, Ma X, Zhou X, Yergeau DA, Wilkinson MR, Vadodaria B, Chen X, McGee RB, Hines-Dowell S, Nuccio R, Quinn E, Shurtleff SA, Rusch M, Patel A, Becksfort JB, Wang S, et al.

N Engl J Med. 2015 Dec 10;373(24):2336-2346. doi: 10.1056/NEJMoa1508054. Epub 2015 Nov 18.

PubMed [citation]
PMID:
26580448
PMCID:
PMC4734119

Improving performance of multigene panels for genomic analysis of cancer predisposition.

Shirts BH, Casadei S, Jacobson AL, Lee MK, Gulsuner S, Bennett RL, Miller M, Hall SA, Hampel H, Hisama FM, Naylor LV, Goetsch C, Leppig K, Tait JF, Scroggins SM, Turner EH, Livingston R, Salipante SJ, King MC, Walsh T, Pritchard CC.

Genet Med. 2016 Oct;18(10):974-81. doi: 10.1038/gim.2015.212. Epub 2016 Feb 4.

PubMed [citation]
PMID:
26845104
See all PubMed Citations (4)

Details of each submission

From Ambry Genetics, SCV000213581.8

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (3)

Description

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Color Diagnostics, LLC DBA Color Health, SCV000681763.6

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Sema4, Sema4, SCV002528010.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedcurationnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 8, 2024